{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:28:19Z","timestamp":1724632099109},"reference-count":15,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1111\/j.1471-0528.2004.00468.x","type":"journal-article","created":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T14:29:33Z","timestamp":1101911373000},"page":"53-56","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Detrusor overactivity\u2014an update"],"prefix":"10.1111","volume":"111","author":[{"given":"P.","family":"Toozs\u2010Hobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Elnaqa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"253","article-title":"Pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Andersson K\u2010E","year":"1993","journal-title":"Pharmacol Rev"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(02)00540-7"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6210.281"},{"key":"e_1_2_6_5_2","first-page":"429","article-title":"Controlled\u2010release oxybutynin maintains efficacy with a 43% reduction in side effects compared to conventional treatment","volume":"16","author":"Birns J","year":"1997","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_6_2","first-page":"533","article-title":"The efficacy, effectiveness, and safety of transdermal oxybutynin in patients with overactive bladder","volume":"22","author":"Dmchowski R","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1998.00717.x"},{"key":"e_1_2_6_8_2","first-page":"478","article-title":"Clinical efficacy and safety of tolterodine compared to oxybutynin in patients with overactive bladder","volume":"16","author":"Kerrebroeck PEVA","year":"1997","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_9_2","first-page":"600","article-title":"A multicenter randomized, placebo controlled trial of trospium chloride in overactive bladder patients","volume":"23","author":"Rudy D","year":"2004","journal-title":"Neuurol Urodyn"},{"key":"e_1_2_6_10_2","first-page":"599","article-title":"Propiverine Hydrochloride immediate (IR) and extended release (ER): comparison of efficacy and tolerability in patients with overactive bladder","volume":"23","author":"Juenemann K","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_11_2","first-page":"534","article-title":"Results of a randomized phase 3 study comparing solifenacin succinate with tolterodine and placebo in patients with symptomatic overactive bladder","volume":"22","author":"Chapple C","year":"2003","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_12_2","first-page":"602","article-title":"Darifenacin, a muscarinic receptor antagonist with selectivity for M3 receptors, reduces incontinence and nocturia in patients with overactive bladder","volume":"23","author":"Hill S","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7394.841"},{"key":"e_1_2_6_14_2","volume-title":"Incontinence in Women","author":"Wilson D","year":"2002"},{"key":"e_1_2_6_15_2","first-page":"S6","article-title":"Anti\u2010diuresis\u2014for the control of daytime incontinence","volume":"13","author":"Robinson D","year":"2002","journal-title":"Int Urogynecol J"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-2838(03)00250-1"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2004.00468.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2004.00468.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:43:20Z","timestamp":1695707000000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2004.00468.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":15,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1471-0528.2004.00468.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00468.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"2004-12-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}